secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARS Pharmaceuticals, Inc. (SPRY)
CIK:        0001671858
Form:       8-K
Filed at:   2022-12-06T23:59:59+00:00
Accession:  0001193125-22-299482
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ARS Pharmaceuticals updates corporate presentation; no material new data disclosed
--------------------------------------------------------------------------------

- Company released an updated slide deck for investor meetings on December 6, 2022.
- Presentation highlights needle-free epinephrine solution for Type I allergic reactions.
- No new clinical, regulatory, or financial milestones were announced in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671858/000119312522299482/0001193125-22-299482-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671858/000119312522299482/d363617d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-299482

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer